Replies to post #335020 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

Yeah, who’d have thunk a paid company adviser would be enthusiastic.

[LIVED]

Was the Brilacidin clinical trial at the same hospital as the Dr's? Stephen T. Sonis, DMD, DMSc, of Brigham and Women's Hospital

[loanranger]

Dr. Sonis collects a few shares/options/shekels every now and then to offer his "advice" on the subject, doesn't he?

Probably more importantly the quote you provided is from September of 2018. Today you can find B-OM perched on the shelf next to B-ABSSSI. The diversion to CoVid didn't happen until a year and a half later.

Should this still be true?
“The lack of preventive or definitive treatment options for patients at risk of, or suffering from, OM is a consistent source of patient misery and leads to costly and clinically significant downstream consequences."
Whose fault is that?

Maybe the Adverse Events aren't significant. Or maybe they explain the unstarted P3. Or maybe they explain why we never saw the minutes of the EOP2 meeting.

You can complain about me asking these questions or you can explain why they haven't been answered. Or both.